• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > Events > ASTMH 2013 > Page 2

ASTMH 2013

13-17 November 2013

Washington DC, United States

  • Panel Discussion
    • Overview
    • Panel Discussion

Panel Discussion

Advancing Life-Saving R&D Innovations for People Living with Chagas Disease – The Silent Killer

This evening panel discussed developing new and innovative life-saving health tools for patients afflicted with Chagas disease, the leading parasitic killer of the Americas.

Chagas disease is a silent killer in Latin America, the US, and internationally. Much more needs to be done today to save the lives of neglected Chagas disease patients, including scaling up screening and treatment, and boosting R&D of new health tools, including drugs, vaccines, and diagnostics.

Coinciding with the American Society of Tropical Medicine and Hygiene (ASTMH) 62nd Annual Meeting, this side event took place at the headquarters of the Pan American Health Organization (PAHO) and brought together patients, researchers, clinicians, and policymakers to shed light on the treatment and research needs of people living with Chagas disease.

Program/speakers:
Program begins at about 05:40:

  • 05:40-08:40: Opening video
  • 08:45-09:30: Introduction by Eric Stobbaerts, DNDi Latin America
  • 09:32-19:05: Peter Hotez, Sabin Vaccine Institute/National School of Tropical Medicine/Baylor College of Medicine
  • 19:05-25:30: Isabela Ribeiro, DNDi
  • 25:39-31:45: Rachel Marcus, Medical Director, LaSocha (US Chagas patients’ association)
  • 32:00-38:00: Sonia Tarragona, Mundo Sano Foundation, representing Global Chagas Disease Coalition
  • 38:11-43:15: Luis Gerardo Castellanos, PAHO
  • 43:20-47:17: Jenny Sanchez, President, LaSocha
  • 47:20-1:09:21: Discussion, moderated by Estrella Lasry, Doctors Without Borders

Speaker bios

Event summary

Event photos

Event flyer


Organizers/Sponsors:

Drugs for Neglected Diseases initiative (DNDi)
Sabin Vaccine Institute
National School of Tropical Medicine
Doctors Without Borders/Médecins Sans Frontières (MSF)
Research!America
American Society of Tropical Medicine and Hygiene (ASTMH)
Pan American Health Organization (PAHO)
Global Chagas Disease Coalition (DNDi, Carlos Slim Health Institute, Sabin Vaccine Institute and Texas Children’s Hospital Center for Vaccine Development and National School of Tropical Medicine at Baylor College of Medicine, Mundo Sano Foundation, CEADES, ISGlobal)

Pages: Page 1, Page 2

Other events

Loading...
20 May 2025

Geneva, Switzerland

Strengthening the global ecosystem for paediatric medicines: leadership, collaboration, and impact

21 May 2025

Geneva, Switzerland

Scaling impact: Climate & health solutions that drive change

7-10 May 2025

Amsterdam, The Netherlands

EASL Congress 2025

20-25 May 2025

Iguaçu Falls, Brazil

22nd ISHAM Congress

See all

Stay connected

Get our latest news, personal stories, research articles, and job opportunities. 

Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License